BIOLARGO, INC. (BLGO) › Cash & EquivalentsBIOLARGO, INC. (BLGO) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2009: $135.3K2010: $425.1K2011: $128.5K2012: $151.2K2013: $92.4K2014: $154.5K2015: $1.76M2016: $1.91M2017: $990.0K2018: $655.0K2019: $655.0K2020: $716.0K2021: $962.0K2022: $1.85M2023: $3.54M2024: $3.55M2025: $3.88M$3.88M2009Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$3.88M+9.4%2024$3.55M+0.3%2023$3.54M+91.2%2022$1.85M+92.4%2021$962.0K+34.4%2020$716.0K+9.3%2019$655.0K+0.0%2018$655.0K-33.8%2017$990.0K-48.2%2016$1.91M+8.3%2015$1.76M+1041.5%2014$154.5K+67.1%2013$92.4K-38.9%2012$151.2K+17.7%2011$128.5K-69.8%2010$425.1K+214.1%2009$135.3K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share